|
Index of reports
> Cases resulting in life threatening events (14)
> Cases with Pyrexia (6)
Below is the selection of adverse event reports related to Trileptal (Oxcarbazepine) that includes cases resulting in life threatening events where reactions include pyrexia.
Adverse event in 20 year old male receiving Trileptal (Oxcarbazepine)
Reported by a physician from France on 2007-10-30
Patient: 20 year old male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: Respiratory Disorder, Blood Creatine Phosphokinase Increased, High Density Lipoprotein Increased, Lymphadenopathy, Urinary Incontinence, Visual Acuity Reduced, Ulcerative Keratitis, Pyrexia, Transaminases Increased, Obstructive Uropathy, C-Reactive Protein Increased, Acute Respiratory Distress Syndrome, Dermatitis Bullous, Mucous Membrane Disorder, Cough, Mechanical Ventilation, Back Pain, Dysphagia, Toxic Epidermal Necrolysis, Corneal Opacity, Prothrombin Time Ratio Decreased, Blood Creatine Phosphokinase MB Increased, Heart Rate Decreased, Rash Erythematous, Ureteral Catheterisation, Renal Colic, Skin Exfoliation, Eye Discharge, Corneal Neovascularisation, Symblepharon, Scab, Intubation, Nephrolithiasis, Corneal Transplant, Microlithiasis, Bone Marrow Failure, Thrombocytopenia, Renal Failure Acute, Catheter Related Complication, Depilation, Cataract, Iris Adhesions, Lacrimation Decreased, Alopecia, Lithotripsy, Asthenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Depakene
Dosage: 1.6 g daily
Indication: Partial Seizures
End date: 2004-11-22
Trileptal
Dosage: 600 mg, bid
Administration route: Oral
Indication: Partial Seizures
Start date: 2005-02-14
End date: 2005-02-21
Depakene
Dosage: 1 g daily
Administration route: Oral
Indication: Partial Seizures
Start date: 2004-11-23
End date: 2004-11-23
Depakene
Dosage: 1.5 g daily
Start date: 2004-11-24
End date: 2005-02-21
Aspegic 325
Indication: Influenza Like Illness
Start date: 2005-02-01
Other drugs received by patient: Rivotril
Adverse event in 8 year old male receiving Trileptal (Oxcarbazepine)
Reported by a physician from France on 2007-06-28
Patient: 8 year old male
Adverse reactions / side effects: Productive Cough, Hepatic Failure, Petechiae, Pyrexia, Hepatitis, Electroencephalogram Abnormal, Thrombocytopenia, Renal Failure Acute, Cough, Alanine Aminotransferase Increased, Convulsion, Fluid Replacement, Diarrhoea, Dehydration, Aspartate Aminotransferase Increased, Increased Bronchial Secretion, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Valproate Sodium
Dosage: unk, unk
Administration route: Oral
Indication: Partial Seizures
Start date: 2002-01-01
End date: 2007-05-28
Trileptal
Dosage: 150 mg, bid
Administration route: Oral
Indication: Partial Seizures
Start date: 2006-01-01
End date: 2007-05-29
Other drugs received by patient: Epitomax; Lioresal; Motilium; Movicol
Adverse event in 20 year old male receiving Trileptal (Oxcarbazepine)
Reported by a consumer/non-health professional from France on 2007-05-17
Patient: 20 year old male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: High Density Lipoprotein Increased, Blood Creatine Phosphokinase Increased, Lymphadenopathy, Respiratory Disorder, Corneal Neovascularisation, Skin Exfoliation, Symblepharon, Scab, Intubation, Ulcerative Keratitis, Pyrexia, Transaminases Increased, Corneal Transplant, C-Reactive Protein Increased, Dermatitis Bullous, Bone Marrow Failure, Acute Respiratory Distress Syndrome, Mucous Membrane Disorder, Thrombocytopenia, Renal Disorder, Dysphagia, Depilation, Toxic Epidermal Necrolysis, Life Support, Iris Adhesions, Blood Creatine Phosphokinase MB Increased, Prothrombin Time Ratio Decreased, Alopecia, Rash Erythematous, Asthenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Depakene
Dosage: 1.6 g daily
Indication: Partial Seizures
End date: 2004-11-22
Trileptal
Dosage: 600 mg, bid
Administration route: Oral
Indication: Partial Seizures
Start date: 2005-02-14
End date: 2005-02-21
Depakene
Dosage: 1 g daily
Administration route: Oral
Indication: Partial Seizures
Start date: 2004-11-23
End date: 2004-11-23
Depakene
Dosage: 1.5 g daily
Start date: 2004-11-24
End date: 2005-02-21
Aspegic 325
Indication: Influenza Like Illness
Start date: 2005-02-01
Other drugs received by patient: Rivotril
Adverse event in 20 year old male receiving Trileptal (Oxcarbazepine)
Reported by a consumer/non-health professional from France on 2007-04-27
Patient: 20 year old male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: High Density Lipoprotein Increased, Blood Creatine Phosphokinase Increased, Lymphadenopathy, Corneal Neovascularisation, Skin Exfoliation, Symblepharon, Scab, Intubation, Ulcerative Keratitis, Pyrexia, Transaminases Increased, C-Reactive Protein Increased, Corneal Transplant, Dermatitis Bullous, Bone Marrow Failure, Acute Respiratory Distress Syndrome, Mucous Membrane Disorder, Thrombocytopenia, Depilation, Dysphagia, Toxic Epidermal Necrolysis, Life Support, Iris Adhesions, Blood Creatine Phosphokinase MB Increased, Prothrombin Time Ratio Decreased, Alopecia, Rash Erythematous, Asthenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Depakene
Dosage: 1.6 g daily
Indication: Partial Seizures
End date: 2004-11-22
Trileptal
Dosage: 600 mg, bid
Administration route: Oral
Indication: Partial Seizures
Start date: 2005-02-14
End date: 2005-02-21
Depakene
Dosage: 1 g daily
Administration route: Oral
Indication: Partial Seizures
Start date: 2004-11-23
End date: 2004-11-23
Depakene
Dosage: 1.5 g daily
Start date: 2004-11-24
End date: 2005-02-21
Aspegic 325
Indication: Influenza Like Illness
Start date: 2005-02-01
Other drugs received by patient: Rivotril
Adverse event in 8 year old male receiving Trileptal (Oxcarbazepine)
Reported by a physician from Germany on 2007-04-03
Patient: 8 year old male, weighing 21.2 kg (46.6 pounds)
Adverse reactions / side effects: Blood Phosphorus Decreased, C-Reactive Protein Increased, Granulocytopenia, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Pyrexia, Leukopenia
Adverse event resulted in: life threatening event
Suspect drug(s):
Trileptal (Oxcarbazepine)
Adverse event in 39 year old male receiving Trileptal (Oxcarbazepine)
Reported by a consumer/non-health professional from United States on 2007-01-05
Patient: 39 year old male, weighing 82.6 kg (181.6 pounds)
Adverse reactions / side effects: Lymphadenopathy, Rash Generalised, Drug Hypersensitivity, Pyrexia
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Tegretol
Indication: Trigeminal Neuralgia
Start date: 1999-07-01
End date: 1999-07-08
Trileptal
Start date: 2002-07-01
End date: 2002-07-02
|
